The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Charles River Laboratories International Inc. shares valued at $354,861 were sold by LaPlume Joseph W on Aug 08 ’24. At $199.36 per share, LaPlume Joseph W sold 1,780 shares. The insider’s holdings dropped to 22,521 shares worth approximately $4.09 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Joseph LaPlume purchased 1,780 shares, netting a total of over 350,000 in proceeds.
Before that, FOSTER JAMES C had sold 25,000 shares from its account. In a trade valued at $6,250,000, the Chairman, President and CEO traded Charles River Laboratories International Inc. shares for $250.00 each. Upon closing the transaction, the insider’s holdings decreased to 25,000 shares, worth approximately $34.15 million.
As published in their initiating research note from CLSA on October 23, 2024, Charles River Laboratories International Inc. [CRL] has been an Underperform and the price target has been revised to $167. Analysts at Redburn Atlantic started covering the stock with ‘”a Sell”‘ outlook in a report released in mid October. As of October 07, 2024, Evercore ISI has decreased its “an Outperform” rating to a “an In-line” for CRL. Earlier on October 02, 2024, BofA Securities downgraded its rating. Their new recommendation was “a Neutral” for CRL stock which previously was a “a Buy”.
Analyzing CRL Stock Performance
During the last five days, there has been a drop of approximately -2.81%. Over the course of the year, Charles River Laboratories International Inc. shares have dropped approximately -23.27%. Shares of the company reached a 52-week high of $275.00 on 03/08/24 and a 52-week low of $180.22 on 10/24/24. A 50-day SMA is recorded $194.81, while a 200-day SMA reached $220.64. Nevertheless, trading volume fell to 0.79 million shares from 0.69 million shares the previous day.
Support And Resistance Levels for Charles River Laboratories International Inc. (CRL)
According to the 24-hour chart, there is a support level at 178.96, which, if violated, would cause prices to drop to 176.54. In the upper region, resistance lies at 185.09. The next price resistance is at 188.80. RSI (Relative Strength Index) is 35.77 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.67, which suggests the price will decrease in the coming days. Percent R is at 94.24%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
